Prostate Cancer Clinical Trials in San Antonio, TX

Prostate Cancer Clinical Trials in San Antonio, TX

View the best 10 prostate cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Prostate Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for prostate cancer in San Antonio, Texas

Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Apalutamide

Antiandrogen

Recruiting2 awardsPhase 3
This trial is testing whether adding apalutamide to standard treatment, with or without targeted radiation therapy, helps patients with prostate cancer that has come back after treatment.
Image of Foothills Urology in Golden, United States.

CAN-2409 Immunotherapy

Cancer Vaccine

Recruiting0 awardsPhase 2
This trial is testing CAN-2409, a treatment that kills prostate cancer cells and boosts the immune system to fight the cancer. It targets patients with localized prostate cancer. The treatment aims to improve their health outcomes by helping their immune system attack the cancer.
Image of Research Site in Lakewood, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Image of Research Site in Tucson, United States.

AZD5305 +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Image of Urology Centers Of Alabama in Homewood, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments on metastatic prostate cancer patients.
Image of NorthShore University HealthSystem in Glenview, United States.

AQUABEAM Robotic System

Procedure

Recruiting1 award
This trial aims to test a new robotic system called AQUABEAM for removing prostate tissue in patients with urinary symptoms and localized prostate cancer. Participants will be monitored for up to 12 months to
Image of Arizona Oncology Associates, PC - HOPE in Tucson, United States.

Nivolumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial will test a new cancer treatment involving two drugs, to see if it is effective, safe, and tolerable for patients with mCRPC.
Image of Moffitt Cancer Center in Tampa, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of University of Alabama at Birmingham (UAB) in Birmingham, United States.

Standard of Care Proton Therapy +3 More

Proton Beam Therapy

Recruiting1 award
This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.